Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01541215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Liraglutide in Combination With Metformin Versus Metformin Monotherapy on Glycaemic Control in Children and Adolescents With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of this trial is to assess the efficacy and safety of liraglutide in the paediatric population in order to potentially address the unmet need for treatment of children and adolescents with type 2 diabetes.
Study identification
- NCT ID
- NCT01541215
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 135 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2012 (Actual)
- Primary completion
- Nov 15, 2017 (Actual)
- Completion
- May 20, 2020 (Actual)
- Last update posted
- Jul 2, 2021
2012 – 2020
United States locations
- U.S. sites
- 71
- U.S. states
- 28
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35233 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85053 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85724-0001 | — |
| Novo Nordisk Investigational Site | Corona | California | 92880 | — |
| Novo Nordisk Investigational Site | Costa Mesa | California | 92626 | — |
| Novo Nordisk Investigational Site | Long Beach | California | 90806 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90027 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90048-1869 | — |
| Novo Nordisk Investigational Site | Moreno Valley | California | 92555 | — |
| Novo Nordisk Investigational Site | Palo Alto | California | 94304-1503 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92123 | — |
| Novo Nordisk Investigational Site | Ventura | California | 93003 | — |
| Novo Nordisk Investigational Site | New Haven | Connecticut | 06511 | — |
| Novo Nordisk Investigational Site | Wilmington | Delaware | 19803 | — |
| Novo Nordisk Investigational Site | Washington D.C. | District of Columbia | 20011 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32256 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33126 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33144 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33155 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33701 | — |
| Novo Nordisk Investigational Site | Tallahassee | Florida | 32308 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33612 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30322 | — |
| Novo Nordisk Investigational Site | Columbus | Georgia | 31904 | — |
| Novo Nordisk Investigational Site | Bloomington | Indiana | 47401 | — |
| Novo Nordisk Investigational Site | Iowa City | Iowa | 52242 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40536-0284 | — |
| Novo Nordisk Investigational Site | Silver Spring | Maryland | 20910 | — |
| Novo Nordisk Investigational Site | Worcester | Massachusetts | 01655 | — |
| Novo Nordisk Investigational Site | Detroit | Michigan | 48201 | — |
| Novo Nordisk Investigational Site | Grand Rapids | Michigan | 49503 | — |
| Novo Nordisk Investigational Site | Saint Paul | Minnesota | 55102 | — |
| Novo Nordisk Investigational Site | Columbia | Missouri | 65201 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64111 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63104 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89128 | — |
| Novo Nordisk Investigational Site | Hackensack | New Jersey | 07601 | — |
| Novo Nordisk Investigational Site | West Orange | New Jersey | 07052 | — |
| Novo Nordisk Investigational Site | Buffalo | New York | 14203 | — |
| Novo Nordisk Investigational Site | New York | New York | 10003 | — |
| Novo Nordisk Investigational Site | New York | New York | 10016 | — |
| Novo Nordisk Investigational Site | New York | New York | 10029 | — |
| Novo Nordisk Investigational Site | Sleepy Hollow | New York | 10591 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45229 | — |
| Novo Nordisk Investigational Site | Toledo | Ohio | 43606 | — |
| Novo Nordisk Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19134 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15224 | — |
| Novo Nordisk Investigational Site | Greenville | South Carolina | 29615 | — |
| Novo Nordisk Investigational Site | Rapid City | South Dakota | 57701 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37403 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38105 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38119-3821 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38119 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37232 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75235 | — |
| Novo Nordisk Investigational Site | Edinburg | Texas | 78539 | — |
| Novo Nordisk Investigational Site | Fort Worth | Texas | 76104 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77054 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77061 | — |
| Novo Nordisk Investigational Site | Kerrville | Texas | 78028 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78233 | — |
| Novo Nordisk Investigational Site | Charlottesville | Virginia | 22908 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23507 | — |
| Novo Nordisk Investigational Site | Charleston | West Virginia | 25302 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01541215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01541215 live on ClinicalTrials.gov.